It will thus be interesting to determine whether allosteric modulation of CD38-enzyme activity in vivo by CD38 nanobodies can counteract its purported immunosuppressive and tumor promoting effects in the tumor microenvironment8. This evidence concerns the gene CD38 and neoplasm.